Pinealon: Published Research

Introduction

Pinealon (Glu-Asp-Arg; EDR) has been the subject of peer-reviewed investigation primarily within Russian research institutions, with findings published in English-language journals and in English translations of Russian-language journals. The published body of work encompasses in vitro cell-culture experiments, rodent behavioral and biochemical studies, and molecular docking analyses. This article summarizes verifiable English-language publications; readers are directed to the original papers via the reference list for full methodology and data. Researchers sourcing the compound for experimental use can review purity documentation on the Pinealon product page.

Methodology Types in the Published Literature

Published Pinealon research has employed several distinct methodological approaches. In vitro studies have used cultured neural cell lines (cerebellar granule cells, pheochromocytoma-derived PC12 cells), primary hippocampal cultures, and non-neural cell lines (HeLa cells, neutrophils). Endpoints have included reactive oxygen species (ROS) quantification, cell viability assays, flow cytometry for necrotic vs. apoptotic proportions, ERK 1/2 phosphorylation status, and dendritic spine counting.

In vivo rodent studies have used rat models (prenatal hyperhomocysteinemia, carotid artery occlusion, streptozotocin-induced diabetes) and transgenic mouse models (5xFAD mice for amyloid-related pathology). Behavioral endpoints in rat studies have included Morris water maze performance (spatial learning and memory), locomotor activity measures, and standard orientation tests. Biochemical endpoints have included caspase-3 activity assays and ROS measurements in ex vivo tissue preparations.

Molecular docking studies have used computational methods to model the interaction between the EDR tripeptide sequence and DNA oligonucleotide targets. These studies report binding energy estimates and identify complementary nucleotide sequences in gene promoter regions, providing a computational framework for subsequent experimental investigation.

Summary of Published Studies

Nuclear Entry and DNA Interaction (2011)

Fedoreyeva, Kireev, Khavinson, and Vanyushin published a study in Biochemistry (Moscow) in 2011 examining the intracellular localization of fluorescein isothiocyanate-labeled short peptides, including the EDR sequence, in HeLa cells [1]. The authors reported that fluorescently labeled EDR peptide was detected in the cytoplasm, nucleus, and nucleolus after cellular incubation, and demonstrated in vitro interaction between the peptide and synthetic deoxyribooligonucleotides. Molecular docking models were constructed for 19 peptide-DNA pairs. This study established the experimental foundation for the hypothesis that Pinealon exerts effects through direct nuclear and genomic engagement rather than surface-receptor signaling — a mechanism described in detail in the Pinealon mechanism of action article.

In Vitro Cell Viability and ROS Study (2011)

Khavinson and colleagues published findings in Rejuvenation Research in 2011 examining Pinealon's effects on ROS accumulation and cell viability across rat cerebellar granule cells, human neutrophils, and PC12 cells [2]. The authors reported that Pinealon exposure was associated with dose-dependent restriction of ROS accumulation induced by oxidative stimuli. The study additionally reported suppression of ERK 1/2 kinase phosphorylation and modification of cell-cycle phase distribution in treated cultures, with reductions in necrotic cell proportions relative to untreated controls.

Findings from research models do not establish safety or efficacy in humans. SpartaLabs makes no claims about the use of this compound.

Antihypoxic Properties Study (2008)

Kozina published research in Advances in Gerontology in 2008 examining the antihypoxic properties of several short regulatory peptides, including Pinealon [3]. Among the peptides examined, Pinealon demonstrated the most pronounced protective effect in the experimental system. The proposed mechanism was described as stimulation of endogenous antioxidant enzyme systems rather than direct radical scavenging — consistent with the SOD2 and GPX1 gene-regulatory interactions later identified through docking analyses.

Prenatal Hyperhomocysteinemia Rat Study (2012)

Arutjunyan and colleagues published findings in the International Journal of Clinical and Experimental Medicine in 2012 reporting outcomes in rat offspring from mothers subjected to elevated dietary methionine [4]. Administration of Pinealon to the pregnant dams was associated with differences in offspring performance on spatial orientation and learning tasks and with altered ROS accumulation and necrotic cell proportions in cerebellar neurons upon ex vivo oxidative challenge. The authors attributed these observations to antioxidant enzyme pathway modulation.

Carotid Occlusion Model in Old Rats (2011)

Mendzheritskiĭ, Karantysh, and Ivonina published findings in Advances in Gerontology in 2011 comparing effects of Pinealon and Cortexin on behavior and caspase-3 activity in aged rats subjected to bilateral carotid artery occlusion [5]. Both compounds were associated with higher survival rates in occluded animals. Pinealon administration prior to occlusion was associated with altered behavioral patterns and modified caspase-3 activity across both sham-operated and occlusion groups.

Serotonin Pathway Gene Regulation (2014)

Khavinson and colleagues published results in the Bulletin of Experimental Biology and Medicine in 2014 describing observations in aging rat brain cortex cell cultures [6]. EDR peptide exposure was associated with observable serotonin immunoreactivity. Molecular docking identified the CCTGCC hexanucleotide in the TPH1 gene promoter (tryptophan hydroxylase 1) as complementary to the EDR sequence, proposed as a mechanism by which the peptide may modulate serotonin biosynthesis at the transcriptional level.

Gene Expression and Alzheimer's Pathogenesis Model (2020)

Khavinson, Linkova, Kozhevnikova, and Trofimova published a review and docking analysis in Molecules in 2020 identifying EDR peptide binding sites computationally in promoters of CASP3, NES, GAP43, APOE, SOD2, PPARA, PPARG, and GPX1 [7]. The authors also reviewed in vitro data reporting reduced ROS levels and preserved neuronal morphology in amyloid-beta toxicity models. The review additionally cited an observation in 72 patients with traumatic brain injury sequelae as part of the broader program context.

Dendritic Spine Preservation in Alzheimer's Mouse Model (2021)

Khavinson and colleagues published experimental results in Pharmaceuticals (Basel) in 2021 using 5xFAD transgenic mice and amyloid-beta-treated hippocampal cultures [8]. EDR peptide was associated with preservation of mushroom-shaped dendritic spine density; the study reported approximately 11% higher mushroom spine density in EDR-treated male 5xFAD mice relative to untreated littermates. Hippocampal cultures showed a reported restoration of mushroom spine number of up to 71% in EDR-treated preparations.

NMDA Receptor Gene Expression in Diabetic Rats (2020)

Karantysh, Fomenko, and colleagues published findings in Neurochemical Journal in 2020 examining Pinealon effects on Morris maze performance and hippocampal NMDA receptor subunit gene expression in streptozotocin-induced diabetic rats [9]. Dose-dependent effects on both behavioral and gene-expression endpoints were reported. This study, from an institution separate from the Khavinson laboratory, represents an extension of Pinealon research into the metabolic disease context.

Active Research Frontier

The Pinealon literature reflects a research program with well-characterized in vitro and preclinical findings across multiple model systems. Translational investigations into human pharmacokinetics — including bioavailability and tissue distribution — represent a natural progression for the field. Genome-wide transcriptomic studies (RNA-seq, ChIP-seq) in mammalian neuronal systems would offer opportunities to corroborate the computational promoter-binding model with experimental data in a controlled setting. The NMDA receptor study from an independent group signals emerging interest from investigators beyond the originating laboratory, a development that broadens the research base for the compound. For comparison, Epithalon published research represents a parallel body of work from the same Khavinson program, examining the related tetrapeptide AEDG across overlapping preclinical contexts.

References

1. Fedoreyeva LI, Kireev II, Khavinson VKh, Vanyushin BF. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry (Moscow). 2011;76(11):1210–1219. doi: 10.1134/S0006297911110022.

2. Khavinson V, Ribakova Y, Kulebiakin K, Vladychenskaya E, Kozina L, Arutjunyan A, Boldyrev A. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Research. 2011;14(5):535–541. doi: 10.1089/rej.2011.1172.

3. Kozina LS. Investigation of antihypoxic properties of short peptides. Advances in Gerontology. 2008;21(1):61–67. PMID: 18546825.

4. Arutjunyan A, Kozina L, Stvolinskiy S, Bulygina Y, Mashkina A, Khavinson V. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. International Journal of Clinical and Experimental Medicine. 2012;5(2):179–185. PMID: 22567179. PMCID: PMC3342713.

5. Mendzheritskiĭ AM, Karantysh GV, Ivonina KO. Effects of introduction of short peptides before carotid artery occlusion on behaviour and caspase-3 activity in the brain of old rats. Advances in Gerontology. 2011;24(1):74–79. PMID: 21809624.

6. Khavinson VKh, Lin'kova NS, Tarnovskaya SI, Umnov RS, Elashkina EV, Durnova AO. Short peptides stimulate serotonin expression in cells of brain cortex. Bulletin of Experimental Biology and Medicine. 2014;157(1):77–80. doi: 10.1007/s10517-014-2496-y.

7. Khavinson V, Linkova N, Kozhevnikova E, Trofimova S. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease. Molecules. 2020;26(1):159. doi: 10.3390/molecules26010159. PMID: 33396470.

8. Khavinson V, Ilina A, Kraskovskaya N, Linkova N, Kolchina N, Mironova E, Erofeev A, Petukhov M. Neuroprotective effects of tripeptides — epigenetic regulators in mouse model of Alzheimer's disease. Pharmaceuticals (Basel). 2021;14(6):515. doi: 10.3390/ph14060515. PMID: 34071923.

9. Karantysh GV, Fomenko MP, Menzheritskii AM, Prokof'ev VN, Ryzhak GA, Butenko EV. Effect of pinealon on learning and expression of NMDA receptor subunit genes in the hippocampus of rats with experimental diabetes. Neurochemical Journal. 2020;14(3):314–320. doi: 10.1134/S181971242003006X.